...
首页> 外文期刊>DNA and Cell Biology >CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population. (Special Issue: Special focus on undergraduate research.)
【24h】

CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population. (Special Issue: Special focus on undergraduate research.)

机译:Cyclin D1转录表达改变的 CCND1 G870A多态性与中国人群脑胶质瘤的风险有关。 (特刊:特别关注本科生研究。)

获取原文
获取原文并翻译 | 示例
           

摘要

A common polymorphism (G870A) in the exon 4/intron 4 boundary of CCND1 gene has been linked to an alternate transcript, cyclin D1 b, which preferentially encodes a protein with an increased transforming capability compared with the full-length D1a. Therefore, the CCND1 G870A polymorphism may influence an individual's susceptibility to the development of certain tumors. In the present study, we investigated the association of CCND1 G870A polymorphism with glioma cancer risk in a northern Chinese population. By polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis, CCND1 G870A genotyping was carried out among 170 glioma patients and 170 age, gender-matched healthy control subjects. The CCND1 870 A allele was more frequently observed in patients than in controls (0.57 vs. 0.48, p=0.03), and an increased risk of glioma cancer was observed for the AA genotype compared with the GG and AG genotypes (odds ratio [OR]=1.828; 95% confidence interval [CI]: 1.150-2.908, p=0.01), particularly among female groups, or ages <=45 groups (OR=2.204, 95% CI: 1.220-3.981, p=0.008). Significant associations were also observed between the AA genotype and glioma risk in the subgroups of World Health Organization (WHO) grade II gliomas and grade III gliomas. Further reverse transcriptase-polymerase chain reaction analysis (RT-PCR) also revealed a stronger positive correlation between the AA genotype and higher cyclin D1 b expression among glioma patients either in the mean quantitative value, or the cyclin D1 b/cyclin D1a ratio in the same tumor tissue (p=0.008, p=0.004, respectively). In conclusion, our data indicate that the CCND1 G870A polymorphism modulated oncogenic cyclin D1 b expression in glioma tissues and may be associated with an increased risk of gliomas in Chinese population.Digital Object Identifier http://dx.doi.org/10.1089/dna.2011.1521
机译:CCND1 基因外显子4 /内含子4边界的一个常见多态性(G870A)已与另一个转录本cyclin D1b连锁,该转录本优先编码一种蛋白质,其转化能力比完整蛋白质更高。长度D1a。因此, CCND1 G870A多态性可能会影响个体对某些肿瘤发展的敏感性。在本研究中,我们调查了中国北方人口中 CCND1 G870A多态性与胶质瘤癌症风险的关系。通过聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析,在170名神经胶质瘤患者和170名年龄,性别匹配的健康对照受试者中进行了 CCND1 G870A基因分型。与对照组相比,患者中更常见 CCND1 870 A等位基因(0.57 vs. 0.48, p = 0.03),并且观察到胶质瘤癌症的风险增加。与GG和AG基因型比较的AA基因型(赔率[OR] = 1.828; 95%置信区间[CI]:1.150-2.908, p = 0.01),尤其是女性群体或年龄< = 45组(OR = 2.204,95%CI:1.220-3.981, p = 0.008)。在世界卫生组织(WHO)的II级神经胶质瘤和III级神经胶质瘤的亚组中,AA基因型与神经胶质瘤的风险之间也存在显着的关联。进一步的逆转录聚合酶链反应分析(RT-PCR)还显示,在神经胶质瘤患者中,AA基因型与较高的细胞周期蛋白D1b表达之间存在更强的正相关性,无论是在平均定量值上还是在细胞周期蛋白D1b / cyclin D1a比相同的肿瘤组织(分别为 p = 0.008, p = 0.004)。总之,我们的数据表明, CCND1 G870A多态性调节胶质瘤组织中致癌细胞周期蛋白D1 b的表达,并可能与中国人群胶质瘤的风险增加有关。 doi.org/10.1089/dna.2011.1521

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号